How Training Works

Every track uses the same core framework: realistic problems, company-specific content, and AI feedback that explains reasoning, not just answers.

  • Company-SpecificEvery problem uses your exact specifications, your acceptance criteria, your method parameters, not generic examples.
  • Always CurrentWhen SOPs change, training updates automatically. No manual rework, no content team required.
  • Candidate PrivacyHiring problems are isolated. Your internal team never sees what candidates are tested on.
  • One UploadTwo pools. Zero manual content creation.
  • Method-CalibratedProblems are calibrated to your company's specific methods, instrument parameters, and specifications.
  • Lab-AccurateAcceptance criteria, method names, and procedure steps match what scientists see day-to-day in the lab.
  • Workflow-AlignedTraining stays relevant to your workflows, not to a generic pharma or biotech template.
  • Version-ControlledContent can be updated as SOPs evolve, so training never drifts out of sync with live procedures.
  • BeginnerFoundational problems with guided reference sheets. Builds pattern recognition and technique-specific vocabulary before introducing ambiguity.
  • IntermediateMixed problems requiring cross-reference between data sources. AI hints available on demand. Guidance without giving the answer away.
  • AdvancedEdge cases, multi-technique problems, and regulatory decision-making scenarios. Closest to what scientists face on live submissions and in regulated lab work.
  • AutomatedAI-generated after each completed training session. No manual scoring or report writing required.
  • Strengths & GapsHighlights strengths by technique and problem type, alongside specific gaps with context on where they showed up.
  • Readiness ScoreIncludes a readiness assessment for live lab work or regulated submissions based on performance pattern.
  • ShareableDirectly with hiring managers, training leads, or included in onboarding records.

Training Tracks

Each track covers a distinct discipline. Start where your role sits, or work across multiple tracks to build broader coverage.

  • Complete synthetic drug datasetRYL-2847, an EGFR inhibitor with all 5 CTD modules, 39 fillable documents, and 56 source documents. Zero compliance risk.
  • Role-based tracksCMC Scientist, Nonclinical, Clinical, Regulatory Affairs, or the full IND. Start where your role sits.
  • Embedded regulatory traps12 traps hidden across the evidence library. Catching them before submission is the point.
  • AI assistantFour modes: Findings, Fillable, Scorecard, and Knowledge. Guidance calibrated to what you need at each stage.
  • Cross-module validationThe engine catches inconsistencies across all 39 documents, the same way a real review cycle would.
  • HPLCSystem suitability judgment, integration errors, blank contamination, column degradation, impurity identification, and method validation scenarios.
  • NMRPeak assignment, solvent vs impurity distinction, unknown compound identification, and structural confirmation problems.
  • Mass SpectrometryMolecular ion identification, fragmentation patterns, isotope interpretation, and degradant localisation.
  • FT-IRIdentity confirmation, contamination detection, functional group analysis, and polymorph distinction.
  • GCRetention time identification, peak area quantification, solvent residue analysis, headspace interpretation, and method suitability assessment.
  • UV-VisAbsorbance spectrum interpretation, Beer-Lambert application, purity assessment, concentration determination, and chromophore identification.
  • SDS-PAGEBand identification, MW estimation from ladder, purity assessment, aggregate detection, and overloaded lane interpretation.
  • SEC-HPLCMonomer/aggregate/fragment percentage, shoulder peak recognition, and spec compliance decisions.
  • qPCRAmplification curve analysis, standard curve validation, NTC contamination, and melt curve interpretation.
  • Flow CytometryGating strategy, population identification, CAR-T phenotyping, and transduction efficiency calculation.
  • ELISA4PL curve validation, hook effect detection, CV acceptance criteria, and relative potency calculation.
  • Cell CultureGrowth curve troubleshooting, viability analysis, metabolite interpretation, and contamination detection.
  • Design ControlsDHF/DMR structure, design input/output traceability, and verification vs validation decision-making.
  • Risk ManagementISO 14971 risk-benefit analysis, FMEA interpretation, and severity/probability scoring practice.
  • Verification and ValidationProtocol review, acceptance criteria gaps, and IQ/OQ/PQ interpretation scenarios.
  • Complaint HandlingMDR reportability decisions, investigation adequacy, and CAPA trigger identification.
  • Regulatory Submissions510(k) predicate selection, substantial equivalence reasoning, and CE marking technical file gap analysis.
  • Clinical ChemistryLevey-Jennings QC interpretation, Westgard rule violations, critical value assessment, delta-check failures, and interference detection (hemolysis, lipemia, icterus).
  • HematologyCBC flag interpretation, peripheral smear morphology review, platelet clumping versus true thrombocytopenia, and critical value release decisions.
  • CoagulationPT/INR and aPTT interpretation, mixing studies (inhibitor versus deficiency), heparin contamination, and DIC panel reasoning.
  • MicrobiologyGram stain interpretation, antibiogram analysis, MIC determination, resistance-pattern recognition, and infection-control alerts.
  • Blood BankABO/Rh discrepancy resolution, antibody panel identification, transfusion reaction workup, and emergency release decisions.
  • Immunology / SerologyANA pattern recognition, infectious-disease serology staging, and protein electrophoresis (M-spike) interpretation.
  • Molecular DiagnosticsViral load quantification, respiratory panel interpretation, pharmacogenomics, and NAAT troubleshooting.
  • UrinalysisDipstick-to-microscopy correlation, crystal and cast identification, and interference detection.
  • Microbiological TestingPathogen detection and enumeration (Salmonella, Listeria, E. coli O157, total plate count), presumptive-versus-confirmed result interpretation, and positive-result release decisions.
  • Pesticide & Residue AnalysisMulti-residue chromatogram interpretation (GC-MS/LC-MS-MS), maximum residue limit (MRL) compliance, and matrix interference assessment.
  • Heavy Metals & ElementalICP-MS and AAS result interpretation, calibration curve validation, detection limit assessment, and regulatory limit compliance (lead, arsenic, cadmium, mercury).
  • Mycotoxins & ContaminantsAflatoxin, ochratoxin, and contaminant quantitation, standard curve validation, and action-limit decisions.
  • Water & EnvironmentalDrinking water and wastewater analysis, microbial and chemical parameter interpretation, EPA method compliance, and exceedance reporting.
  • Nutritional & CompositionalProximate analysis, label-claim verification, allergen testing, and specification compliance for food products.